301393.SZ · 昊帆生物
China A-shares · RS rating 83 · As of 2026-10-14
| Price | 58.30 CNY |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 83 / 86 / 38 / 74 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 47 / 43 / 26 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +20.6% |
| Distance from 52-week high | +18.5% |
| Market cap (USD) | $1.0B |